Physician profile
Tera Beaird
NPI 1841261195
$2,461.90
in general payments reported to CMS, 2019-2025
17 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.38 · 2022: $801 · 2023: $1,211 · 2024: $272 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $646.29 | 2021-2025 | |
| Abbott Laboratories | $616.82 | 2022-2025 | Jot Dx, Gallant, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $191.01 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $173.76 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.26 | 2022-2023 | Jardiance |
| Amgen INC. | $99.67 | 2022-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $96.78 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $95.19 | 2022-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $87.05 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.89 | 2022-2023 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $67.26 | 2023-2024 | Inpefa |
| Pfizer INC. | $61.62 | 2022-2023 | |
| Boston Scientific Corporation | $36.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.35 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $23.94 | 2023 | Opsumit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $20.97 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.57 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tera Beaird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.